Brief: Forward Pharma sues Biogen Idec over Tecfidera(R) sales in Germany
Nov 18 (Reuters) - Forward Pharma A/S FWP.O : * Sues Biogen Idec over Tecfidera(R) sales in germany * Seeks damages for what the company believes are Biogen idec's unlawful sales of tecfidera in germany * Says expects that the regional court in Dusseldorf will render a decision before the end of 2015 * Source text for Eikon ID:nGNXVCCUZa * Further company coverage FWP.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA